These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Inhalation of a prostacyclin analog (iloprost) in primary and secondary pulmonary hypertension]. Andreassen AK, Madsen S, Kjekshus J, Simonsen S. Tidsskr Nor Laegeforen; 2001 Apr 20; 121(10):1220-3. PubMed ID: 11402748 [Abstract] [Full Text] [Related]
15. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. Hoeper MM, Schwarze M, Ehlerding S, Adler-Schuermeyer A, Spiekerkoetter E, Niedermeyer J, Hamm M, Fabel H. N Engl J Med; 2000 Jun 22; 342(25):1866-70. PubMed ID: 10861321 [Abstract] [Full Text] [Related]
16. Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients. Frey B, Pacher R, Locker G, Bojic A, Hartter E, Woloszczuk W, Stanek B. Chest; 2000 Jun 22; 117(6):1713-9. PubMed ID: 10858407 [Abstract] [Full Text] [Related]
17. [Are there pulmonary vascular or respiratory effects of prostaglandin vehicles (ethanol, glycine buffer) after intravenous infusion or inhalation?]. Bund M, Winterhalter M, Weilbach C, Piepenbrock S. Pneumologie; 2007 Nov 22; 61(11):721-4. PubMed ID: 17729206 [Abstract] [Full Text] [Related]